Skip to content

ReDirection / Self-Guided ICBT to Reduce the Risk of Child Sexual Abuse Material (CSAM) Use

Evaluation of an Online Self-Help Program for CSAM

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06778044
Enrollment
300
Registered
2025-01-16
Start date
2025-01-15
Completion date
2025-11-30
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pedophilia

Keywords

Child Sexual Abuse Material, Paraphilic Disorders, Waitlist, Child sexual abuse, Cognitive behavioural therapy, Self-help intervention, Internet based intervention, Prevention, Pedophilic disorder

Brief summary

The creation and distribution of child sexual abuse material (CSAM) is a large-scale global problem. CSAM is sometimes referred to as child pornography. It includes images, videos, live-streaming, and any other material that depicts sexual acts with a child or adolescent (i.e., a person under the age of 18). It also includes material that shows a child or adolescent in a sexually suggestive or explicit manner partially clothed, or nude, and can include material that does or does not illustrate sexual activity. CSAM use is a problem that continues to drastically increase in size despite the numerous political, police, and technological initiatives that have been put forth as solutions. Previous research also suggests that many active CSAM users desire help to stop their use, but have experienced difficulties finding support that is anonymous. Thus, there is a great need for anonymous intervention programs that assist active and at-risk CSAM users in developing skills to manage their thoughts, feelings, and behaviours related to CSAM. ReDirection is a free, anonymous, online, self-guided, cognitive behavioural therapy (CBT)-based program for individuals concerned about their use or risk to use CSAM. The treatment program is based on many years of clinical experience working with patients who have committed sexual offences, and the results of several previous research projects. This study will implement a scientifically rigorous design (a three-armed randomized waitlist-controlled trial) to evaluate two versions of this intervention (ReDirection 1.0 and ReDirection 2.0). The primary difference between the two versions of ReDirection is the length of the program and whether it includes the option for asynchronous messaging with a ReDirection specialist. The study design compares ReDirection 1.0 and ReDirection 2.0 with a waitlist control group. Participants in the waitlist control will wait six weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing about sexual urges and behaviours. Participants will be recruited directly from the ReDirection website, where they will be directed to a secure platform designed specifically for clinical trials of internet-mediated CBT. This platform is called Iterapi. Potential participants learn about the ReDirection program through advertisements on both the Clearnet and Darknet. All trial activities, including participant registration, random assignment, intervention, and evaluation will be conducted via Iterapi. Treatment includes five-to-six modules over five-to-six weeks and the content includes CBT-based psychoeducation and exercises that aim to help participants gain greater understanding of, and skills to manage risky sexual thoughts, feelings, and behaviours.

Interventions

OTHERReDirection 1.0

A free, anonymous, online, self-guided cognitive behavioral therapy (CBT) intervention. Consists of 6 modules.

OTHERReDirection 2.0

A free, anonymous, online, self-guided, cognitive behavioural therapy (CBT) intervention. Consists of 5 modules and the option for asynchronous messaging with a ReDirection specialist.

OTHERWaitlist

Participants in the waitlist control will wait six weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing sexual urges and behaviour.

Sponsors

Johns Hopkins Bloomberg School of Public Health
CollaboratorOTHER
Protect Children Organisation, Finland
CollaboratorUNKNOWN
The Royal Ottawa Mental Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A three-arm randomized controlled trial where two treatment arms (ReDirection 1.0 and ReDirection 2.0) are compared to a waitlist control.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Able to read and understand English or Spanish * Have used or experienced urges to use CSAM within the last six months

Exclusion criteria

* Younger than 18 years of age * Unable to read and understand English or Spanish * Have not used or experienced urges to use CSAM within the last six months

Design outcomes

Primary

MeasureTime frameDescription
Do ReDirection 1.0 and ReDirection 2.0 reduce participants' urges to use CSAM?Up to 8 weeksUrges to use CSAM is measured using a modified version of the SSAS (Sexual Symptom Assessment Scale), which is a self-rated measure originally developed to assess general sexual compulsive behaviour. This measure was adapted to include language specific to CSAM use, and response options were altered to permit more precise measurement. There's no scoring system at the moment. It's all item-by-item. But for all items, higher values indicated a greater frequency, intensity, and/or duration of urges.

Secondary

MeasureTime frameDescription
Do ReDirection 1.0 and ReDirection 2.0 reduce participants' proclivity to offend?Up to 8 weeksProclivity to offend is defined as likelihood to engage in offending behaviour if no one were to ever find out and the individual could not be punished. This is assessed using two separate items created for this study: one for likelihood of CSAM use and one for likelihood of sexual contact with a person 15 years of age or younger. These are each measured as a likelihood from 0 \[minimum\] to 100 \[maximum\]. A 0 indicates 'no chance' whereas 100 indicates 'guaranteed'

Countries

Canada, Finland

Contacts

Primary ContactCarissa Augustyn, PhD
redirectionprogram@proton.me780-497-5003
Backup ContactMichael Seto, PhD
michael.seto@theroyal.ca613-803-0792

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026